|
1
|
Balch CM, Soong SJ, Gershenwald JE,
Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross
MI, Kirkwood JM, et al: Prognostic factors analysis of 17,600
melanoma patients: Validation of the American Joint Committee on
Cancer melanoma staging system. J Clin Oncol. 19:3622–3634. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Balch CM, Soong SJ, Smith T, Ross MI,
Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell
WR, et al: Long-term results of a prospective surgical trial
comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4
mm melanomas. Ann Surg Oncol. 8:101–108. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Slominski A, Wortsman J, Carlson AJ,
Matsuoka LY, Balch CM and Mihm MC: Malignant melanoma. Arch Pathol
Lab Med. 125:1295–1306. 2001.PubMed/NCBI
|
|
4
|
Balch CM, Buzaid AC, Soong SJ, Atkins MB,
Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr,
Kirkwood JM, et al: Final version of the American Joint Committee
on Cancer staging system for cutaneous melanoma. J Clin Oncol.
19:3635–3648. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morton DL, Wen DR, Wong JH, Economou JS,
Cagle LA, Storm FK, Foshag LJ and Cochran AJ: Technical details of
intraoperative lymphatic mapping for early stage melanoma. Arch
Surg. 127:392–399. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baggiolini M and Loetscher P: Chemokines
in inflammation and immunity. Immunol Today. 21:418–420. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–242. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sánchez-Martin L, Sánchez-Mateos P and
Cabañas C: CXCR7 impact on CXCL12 biology and disease. Trends Mol
Med. 19:12–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beutner KR, Geisse JK, Helman D, Fox TL,
Ginkel A and Owens ML: Therapeutic response of basal cell carcinoma
to the immune response modifier imiquimod 5% cream. J Am Acad
Dermatol. 41:1002–1007. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rowe DE, Carroll RJ and Day CL Jr:
Prognostic factors for local recurrence, metastasis, and survival
rates in squamous cell carcinoma of the skin, ear, and lip.
Implications for treatment modality selection. J Am Acad Dermatol.
26:976–990. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaw LM: Tumor cell invasion assays.
Methods Mol Biol. 294:97–105. 2005.PubMed/NCBI
|
|
14
|
Yang FC, Atkinson SJ, Gu Y, Borneo JB,
Roberts AW, Zheng Y, Pennington J and Williams DA: Rac and Cdc42
GTPases control hematopoietic stem cell shape, adhesion, migration,
and mobilization. Proc Natl Acad Sci USA. 98:5614–5618. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsareva SA, Moriggl R, Corvinus FM,
Wiederanders B, Schütz A, Kovacic B and Friedrich K: Signal
transducer and activator of transcription 3 activation promotes
invasive growth of colon carcinomas through matrix
metalloproteinase induction. Neoplasia. 9:279–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giard DJ, Aaronson SA, Todaro GJ, Arnstein
P, Kersey JH, Dosik H and Parks WP: In vitro cultivation of human
tumors: Establishment of cell lines derived from a series of solid
tumors. J Natl Cancer Inst. 51:1417–1423. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sulit HL, Golub SH, Irie RF, Gupta RK,
Grooms GA and Morton DL: Human tumor cells grown in fetal calf
serum and human serum: Influences on the tests for lymphocyte
cytotoxicity, serum blocking and serum arming effects. Int J
Cancer. 17:461–468. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Larionov A, Krause A and Miller W: A
standard curve based method for relative real time PCR data
processing. BMC Bioinformatics. 6:622005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12/CXCR4/CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Shiozawa Y, Wang J, Wang Y, Jung
Y, Pienta KJ, Mehra R, Loberg R and Taichman RS: The role of
CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate
cancer. J Biol Chem. 283:4283–4294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huggenberger R and Detmar M: The cutaneous
vascular system in chronic skin inflammation. J Investig Dermatol
Symp Proc. 15:24–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tarnowski M, Liu R, Wysoczynski M,
Ratajczak J, Kucia M and Ratajczak MZ: CXCR7: A new SDF-1-binding
receptor in contrast to normal CD34(+) progenitors is functional
and is expressed at higher level in human malignant hematopoietic
cells. Eur J Haematol. 85:472–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Alterio C, Consales C, Polimeno M,
Franco R, Cindolo L, Portella L, Cioffi M, Calemma R, Marra L,
Claudio L, et al: Concomitant CXCR4 and CXCR7 expression predicts
poor prognosis in renal cancer. Curr Cancer Drug Targets.
10:772–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pinto S, Martinez-Romero A, O'Connor JE,
Gil-Benso R, San-Miguel T, Terrádez L, Monteagudo C and Callaghan
RC: Intracellular coexpression of CXC- and CC-chemokine receptors
and their ligands in human melanoma cell lines and dynamic
variations after xenotransplantation. BMC Cancer. 14:1182014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Richmond A, Yang J and Su Y: The good and
the bad of chemokines/chemokine receptors in melanoma. Pigment Cell
Melanoma Res. 22:175–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Longo-Imedio MI, Longo N, Treviño I,
Lázaro P and Sánchez-Mateos P: Clinical significance of CXCR3 and
CXCR4 expression in primary melanoma. Int J Cancer. 117:861–865.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Monteagudo C, Martin JM, Jorda E and
Llombart-Bosch A: CXCR3 chemokine receptor immunoreactivity in
primary cutaneous malignant melanoma: Correlation with
clinicopathological prognostic factors. J Clin Pathol. 60:596–599.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Levoye A, Balabanian K, Baleux F,
Bachelerie F and Lagane B: CXCR7 heterodimerizes with CXCR4 and
regulates CXCL12-mediated G protein signaling. Blood.
113:6085–6093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee E, Han J, Kim K, Choi H, Cho EG and
Lee TR: CXCR7 mediates SDF1-induced melanocyte migration. Pigment
Cell Melanoma Res. 26:58–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sierro F, Biben C, Martinez-Muñoz L,
Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M,
et al: Disrupted cardiac development but normal hematopoiesis in
mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc
Natl Acad Sci USA. 104:14759–14764. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salazar N, Muñoz D, Kallifatidis G, Singh
RK, Jordà M and Lokeshwar BL: The chemokine receptor CXCR7
interacts with EGFR to promote breast cancer cell proliferation.
Mol Cancer. 13:1982014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh RK and Lokeshwar BL: The
IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling
to promote prostate cancer growth. Cancer Res. 71:3268–3277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
